← FDA Drug Approvals (Drugs@FDA)

NIKTIMVO

BLA · Biologics License Application · Sponsor: INCYTE CORP · Approved 2024-08-14

Drug application

FDA Application #

BLA761411

Application type

Biologics License Application

Brand name

NIKTIMVO

Generic name

AXATILIMAB-CSFR

Active ingredients

axatilimab-csfr

Dosage form

INJECTABLE

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

INCYTE CORP

Manufacturer

Incyte Corporation

First approval

2024-08-14

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown